ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Pharmala Biotech Holdings Inc

Pharmala Biotech Holdings Inc (MDMA)

0.31
0.045
(16.98%)
Closed January 10 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.31
Bid
0.275
Ask
0.31
Volume
518,237
0.235 Day's Range 0.31
0.065 52 Week Range 0.35
Previous Close
0.265
Open
0.265
Last Trade
20000
@
0.31
Last Trade Time
Average Volume (3m)
482,840
Financial Volume
-
VWAP
-

MDMA Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.03512.72727272730.2750.3250.2354356560.29394875CS
40.0834.78260869570.230.3250.1953767190.26176804CS
120.17121.4285714290.140.340.134828400.25632899CS
260.195169.5652173910.1150.340.0653347540.20144612CS
520.1593.750.160.350.0654117260.20272268CS
156-0.13-29.54545454550.440.540.025682730.19139933CS
260-0.13-29.54545454550.440.540.025682730.19139933CS

MDMA - Frequently Asked Questions (FAQ)

What is the current Pharmala Biotech share price?
The current share price of Pharmala Biotech is $ 0.31
What is the 1 year trading range for Pharmala Biotech share price?
Pharmala Biotech has traded in the range of $ 0.065 to $ 0.35 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPSSweet Poison Spirits Inc
$ 0.13
(225.00%)
580k
SQXSquatex Energy and Ressources Inc
$ 0.01
(100.00%)
1,000
TGLDTorrent Gold Inc
$ 0.10
(66.67%)
17k
CHGXChitogenX Inc
$ 0.025
(66.67%)
214.5k
HROHero Innovation Group Inc
$ 0.15
(50.00%)
12.53k
EPIC1CM Inc
$ 0.255
(-49.00%)
9.5k
SKURSekur Private Data Ltd
$ 0.02
(-33.33%)
669.03k
RFRRenforth Resources Inc
$ 0.01
(-33.33%)
57k
MYTCMyndTec Inc
$ 0.20
(-33.33%)
1,000
TAATTAAT Global Alternatives Inc
$ 0.17
(-26.09%)
5.5k
PKKPeak Fintech Group Inc
$ 0.05
(-9.09%)
4.96M
QIMCQuebec Innovative Materials Corp
$ 0.11
(4.76%)
3.27M
CVGRCity View Green Holdings Inc
$ 0.01
(33.33%)
2.35M
CATCAT Strategic Metals Corporation
$ 0.005
(0.00%)
2.33M
PREVPreveCeutical Medical Inc
$ 0.035
(16.67%)
1.71M

MDMA Discussion

View Posts
lolroflmao lolroflmao 2 months ago
PharmAla Reaches Agreement In Principle to Supply MDMA to Clinical Trial in Exchange for Full Data License

https://pharmala.ca/media/2024/11/pharmala-reaches-agreement-in-principle-to-supply-mdma-to-clinical-trial-in-exchange-for-full-data-license

πŸ‘οΈ0
lolroflmao lolroflmao 2 months ago
News: PharmAla to supply LaNeo MDMA for Clinical Trial at Yale

https://pharmala.ca/media/2024/11/pharmala-to-supply-laneo-mdma-for-clinical-trial-at-yale

πŸ‘οΈ0
lolroflmao lolroflmao 2 months ago

PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA Press Release | 10/21/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Mt-Sinai-Hospital-with-LaNeo-MDMA?id=456329

πŸ‘οΈ0
lolroflmao lolroflmao 2 months ago
PharmAla to supply the University of Texas, San Antonio, with novel dosage form of LaNeo™ MDMA Press Release | 10/08/2024

https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-the-University-of-Texas-San-Antonio-with-novel-dosage-form-of-LaNeo-MDMA?id=455196

πŸ‘οΈ0
lolroflmao lolroflmao 2 months ago
PharmAla to supply Harvard Medical School’s Maclean Hospital with LaNeo MDMAPress Release | 10/02/2024
https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Harvard-Medical-Schools-Maclean-Hospital-with-LaNeo-MDMA?id=454666
πŸ‘οΈ0
lolroflmao lolroflmao 2 months ago
PharmAla to supply Johns Hopkins Medicine for Clinical TrialPress Release | 09/11/2024


https://www.otcmarkets.com/stock/MDXXF/news/PharmAla-to-supply-Johns-Hopkins-Medicine-for-Clinical-Trial?id=452770
πŸ‘οΈ0
Dewayne18 Dewayne18 2 years ago
$MDMA New Short Call: Shorts in at 30 cents today. Stay tuned tomorrow for details of its pending doom. Last call 34% in less than 2 days.
πŸ‘οΈ0
Dewayne18 Dewayne18 2 years ago
$MDMA SHORT ALERT!!!

Company up on lousy $50,000 deal.... Shorts in at 38 cents CDN.

Quick 30%

Act Now!!!
πŸ‘οΈ0
Dewayne18 Dewayne18 2 years ago
$MDMA is looking like the perfect short. The SP is racing up and the company only has 700K left with shares doubling up in the past 12 months. Over the past 12 months cash went down by 1.2 million.
πŸ‘οΈ0
Forcealpine Forcealpine 3 years ago
It looks like this IPO has gone similarly to all psych companies have. The industry needs a massive correction, but that cannot happen until government stop obsessing over vaccines and start promoting alternative solutions to the gigantic mental health crisis ongoing and perpetuating daily while being ignored. MDMA looks promising and I'll be keeping a very close eye on its news and resulting share price.
πŸ‘οΈ0

Your Recent History

Delayed Upgrade Clock